Cataract & Refractive 360: Fundamentals, Techniques & Technology; Volume 4, Number 1

1.25 CME
$0 FEE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Cataract & Refractive 360: Fundamentals, Techniques & Technology


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by educational grants from Alcon Vision, LLC; Carl Zeiss Meditec, Inc.; and J&J Vision.

Target Audience

The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients undergoing cataract surgery.

Learning Objective(s)

Upon successful completion of this publication series, participants should be better able to: 

  • Review the role of fluidics and ultrasound in cataract surgery and how the risk of associated complications may be minimized during their use.
  • Evaluate advances in presurgical/surgical diagnostics and intraoperative guidance systems and their impact on improved refractive outcomes.
  • List the benefits and limitations of femtosecond laser in cataract surgery.
  • Investigate the surgical techniques necessary to optimize outcomes in complex cases.
  • Review the impact on refractive outcomes of cataract surgery-induced and preexisting astigmatism.
  • Explore diagnostic and surgical techniques that can be used to correct astigmatism before, during, and after cataract removal.
  • Compare the available types of intraocular lenses and determine their influence on visual outcomes.
  • Assess the importance of presurgical screening and discussion with the patient for intraocular lens selection to ensure patient satisfaction with outcomes.
  • Summarize the need for presurgical planning prior to refractive procedures.
  • Compare advanced techniques and technology for guiding refractive surgery to reduce complications and achieve better visual outcomes.
  • Evaluate the evidence supporting the use of femtosecond laser in refractive surgery.

Chief Medical Editor

Terry Kim, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division 
Director, Refractive Surgery Service 
Duke University Eye Center 
Durham, NC

Editorial Board

Nicole R. Fram, MD
Partner, Advanced Vision Care
Clinical Instructor of Ophthalmology
Stein Eye Institute
Los Angeles, CA

Sumit (Sam) Garg, MD
Vice Chair of Clinical Ophthalmology
Medical Director
Associate Professor – Corneal, Cataract, and Refractive Surgery 
Gavin Herbert Eye Institute 
University of California 
Irvine, CA

Elizabeth Yeu, MD
Assistant Professor of Ophthalmology
Eastern Virginia Medical School
Partner, Virginia Eye Consultants
Cornea, Cataract, Anterior Segment, and Refractive Surgery Specialist 
Norfolk, VA
*Faculty Contributor also for this issue.


Brandon D. Ayres, MD
Cornea Service
Co-Director of Cornea Fellowship
Wills Eye Hospital
Philadelphia, PA

Rosa M. Braga-Mele, MEd, MD, FRCSC
Professor of Ophthalmology
Director, Professionalism and BioMedical Ethics 
Department of Ophthalmology 
University of Toronto 
Director of Cataract Surgery 
Kensington Eye Institute 
Toronto, Canada

Gary J.L. Foster, MD
Eye Center of Northern Colorado, P.C.
Fort Collins, CO
Medical Director
Eye Laser Center of Northern Colorado
Loveland, CO

William B. Trattler, MD
Director of Cornea
Center for Excellence in Eye Care
Volunteer Faculty
Florida International University
Herbert Wertheim College of Medicine
Miami, FL

Medical Writer

Valerie Zimmerman, PhD


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, October 25, 2019, through October 25, 2020.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, and complete the posttest and evaluation. Provide only one (1) correct answer for the question. A satisfactory score is defined as answering the posttest question correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Chief Medical Editor, Editorial Board, and Faculty report the following relationship(s):

Brandon D. Ayres, MD
Consulting Fee: Alcon, Allergan, Bio-Tissue, Eyevance, Kala, MicroSurgical Technology, Omeros, Shire, Sight Sciences, Zeiss 
Speakers Bureau: Alcon, Allergan

Rosa M. Braga-Mele, MEd, MD, FRCSC
Consulting Fee: Alcon, J&J Vision, Zeiss

Gary J.L. Foster, MD
Consulting Fee: Alcon
Contracted Research:
AcuFocus, Alcon, Bausch + Lomb 
Ownership Interest:
AcuFocus, ThruFocus

Nicole R. Fram, MD
Consulting Fee: Aerie, Alcon, Allergan, CorneaGen, J&J Vision, Ocular Science, W.L. Gore, Zeiss 
Speakers Bureau: Alcon, Bausch + Lomb, Dompè, J&J Vision, Novartis, Shire, Sun 
Contracted Research: Alcon, Allergan 
Ownership Interest: CorneaGen, Ocular Science

Sumit (Sam) Garg, MD
Consulting Fee: Avedro, CorneaGen, EyePoint, Eyevance, J&J Vision, Kala, Katena, Takeda, Verana Health, VisionCare, Zeiss
Speakers Bureau:
J&J Vision, Takeda
Ownership Interest:
Equinox, Expert Opinion, LensGen, Ocutrx, RPS

Terry Kim, MD
Consulting Fee: Aerie, Alcon/Novartis, Allergan/Actavis, Avedro, Avellino Labs, Bausch + Lomb/Valeant, BlephEx, CoDa/Ocunexus Therapeutics, Kala, NovaBay, Ocular Therapeutix, Omeros, PowerVision, Presbyopia Therapies, Shire, Simple Contacts, TearLab, Zeiss 
Ownership Interest: Avellino Labs, CorneaGen, Kala, NovaBay, Ocular Therapeutix, Omeros, Simple Contacts

William B. Trattler, MD
Consulting Fee: Abbott Medical Optics, Alcon, Allergan, Avedro, Bausch + Lomb, BlephEx, CXLO, Iantech, Kala, Omeros, Ocular Therapuetix, Shire, Sun, Tear Science 
Speakers Bureau: Abbott Medical Optics, Allergan, Avedro, Bausch + Lomb, Iantech, NovaBay, Shire, Sun 
Ownership Interest: Alphaeon, Avedro, CXLO, Iantech, Intelligent Diagnostics, RPS, Visionary Fund

Elizabeth Yeu, MD
Consulting Fee: Alcon, Allergan, ArcScan, Aurea Medical, Avedro, Bausch + Lomb, Bio-Tissue, BVI, EyePoint, Expert Opinion, Glaukos, i-Optics, J&J Vision, Kala, LENSAR, Merck, Mynosys, Novartis, Ocular Science, Ocular Therapeutix, OCuSOFT, Oyster Point, Science Based Health, Shire, Sun, TearLab, Veracity, Zeiss
Speakers Bureau:
Alcon, Allergan, BioTissue, J&J Vision, Ocular Therapeutix, Omeros, Shire, TearLab
Contracted Research:
Alcon, Allergan, Bausch + Lomb, Bio-Tissue, i-Optics, Kala, Topcon
Ownership Interest:
ArcScan, CorneaGen, Modernizing Medicine, Ocular Science, Oyster Point, Strathspey Crown

Medical Writer reports the following relationship(s):

Valerie Zimmerman, PhD
No relevant financial relationships to disclose.

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at